Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX-2 Inhibitors with Anticancer and Anti-inflammatory Activities


HIDIR A., OSMANİYE D., SAĞLIK ÖZKAN B. N., LEVENT S., KAPLANCIKLI Z. A., ÖZKAY Y.

ACS OMEGA, cilt.10, sa.51, ss.63276-63292, 2025 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 51
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1021/acsomega.5c09752
  • Dergi Adı: ACS OMEGA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, Directory of Open Access Journals
  • Sayfa Sayıları: ss.63276-63292
  • Anadolu Üniversitesi Adresli: Evet

Özet

In this study, 20 new compounds with thiadiazole structures were synthesized based on Alpelisib. The benzene ring, a bioisostere of the pyridine ring in the lead compound, was used in the synthesized compounds, and derivatives containing different substituents were used to observe modifications that could affect activity. Furthermore, because combined therapies are known to be more effective in cancer therapy, attempts were made to design compounds capable of dual inhibition of EGFR-COX-2 by adding sulfonamide substitutions to some compounds. The structures of the compounds were confirmed by IR, 1H NMR, 13C NMR, and HRMS spectral analyses. A549 and MCF-7 cell lines were used to measure anticancer activity, and in vitro assays were conducted. For compounds 3j and 3o, further activity studies, molecular docking, and molecular dynamics studies were performed. The compounds' EGFR and COX-2 inhibitory potential was investigated.